vorinostat has been researched along with Precursor B-Cell Lymphoblastic Leukemia-Lymphoma in 3 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and adolescents and characterized by a high number of lymphoblasts and solid tumor lesions. Frequent sites involve LYMPH NODES, skin, and bones. It most commonly presents as leukemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davies, C | 2 |
| Hogarth, LA | 2 |
| Mackenzie, KL | 2 |
| Hall, AG | 2 |
| Lock, RB | 2 |
| Suzuki, K | 1 |
| Okuno, Y | 1 |
| Kawashima, N | 1 |
| Muramatsu, H | 1 |
| Okuno, T | 1 |
| Wang, X | 1 |
| Kataoka, S | 1 |
| Sekiya, Y | 1 |
| Hamada, M | 1 |
| Murakami, N | 1 |
| Kojima, D | 1 |
| Narita, K | 1 |
| Narita, A | 1 |
| Sakaguchi, H | 1 |
| Sakaguchi, K | 1 |
| Yoshida, N | 1 |
| Nishio, N | 1 |
| Hama, A | 1 |
| Takahashi, Y | 1 |
| Kudo, K | 1 |
| Kato, K | 1 |
| Kojima, S | 1 |
| Dietrich, PA | 1 |
| Bachmann, PS | 1 |
3 other studies available for vorinostat and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; B-Lymphocytes; Caspase 3; Caspase 7; Cell Cycle Checkp | 2015 |
MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents.
Topics: Adolescent; Bortezomib; Cell Line, Tumor; Child; Dexamethasone; Drug Screening Assays, Antitumor; HE | 2016 |
p53-independent epigenetic repression of the p21(WAF1) gene in T-cell acute lymphoblastic leukemia.
Topics: Acetylation; Adolescent; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Child; Child, Presch | 2011 |